Literature DB >> 28577984

Protein kinase D signaling in cancer: A friend or foe?

Adhiraj Roy1, Jing Ye2, Fan Deng3, Qiming Jane Wang4.   

Abstract

Protein kinase D is a family of evolutionarily conserved serine/threonine kinases that belongs to the Ca++/Calmodulin-dependent kinase superfamily. Signal transduction pathways mediated by PKD can be triggered by a variety of stimuli including G protein-coupled receptor agonists, growth factors, hormones, and cellular stresses. The regulatory mechanisms and physiological roles of PKD have been well documented including cell proliferation, survival, migration, angiogenesis, regulation of gene expression, and protein/membrane trafficking. However, its precise roles in disease progression, especially in cancer, remain elusive. A plethora of studies documented the cell- and tissue-specific expressions and functions of PKD in various cancer-associated biological processes, while the causes of the differential effects of PKD have not been thoroughly investigated. In this review, we have discussed the structural-functional properties, activation mechanisms, signaling pathways and physiological functions of PKD in the context of human cancer. Additionally, we have provided a comprehensive review of the reported tumor promoting or tumor suppressive functions of PKD in several major cancer types and discussed the discrepancies that have been raised on PKD as a major regulator of malignant transformation.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Function; PKD; Regulation; Signaling mechanisms; Structure

Mesh:

Substances:

Year:  2017        PMID: 28577984      PMCID: PMC5548606          DOI: 10.1016/j.bbcan.2017.05.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta Rev Cancer        ISSN: 0304-419X            Impact factor:   10.680


  189 in total

1.  Role of hydrophobic residues in the C1b domain of protein kinase C delta on ligand and phospholipid interactions.

Authors:  Q J Wang; T W Fang; K Nacro; V E Marquez; S Wang; P M Blumberg
Journal:  J Biol Chem       Date:  2001-03-14       Impact factor: 5.157

Review 2.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

3.  Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal.

Authors:  L E Benjamin; E Keshet
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

Review 4.  Lessons from the cancer genome.

Authors:  Levi A Garraway; Eric S Lander
Journal:  Cell       Date:  2013-03-28       Impact factor: 41.582

Review 5.  Physiological functions of protein kinase D in vivo.

Authors:  Kornelia Ellwanger; Angelika Hausser
Journal:  IUBMB Life       Date:  2013-01-03       Impact factor: 3.885

6.  A novel tyrosine phosphorylation site in protein kinase D contributes to oxidative stress-mediated activation.

Authors:  Heike Döppler; Peter Storz
Journal:  J Biol Chem       Date:  2007-09-05       Impact factor: 5.157

7.  Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands.

Authors:  Ilan Weinreb; Salvatore Piscuoglio; Luciano G Martelotto; Daryl Waggott; Charlotte K Y Ng; Bayardo Perez-Ordonez; Nicholas J Harding; Javier Alfaro; Kenneth C Chu; Agnes Viale; Nicola Fusco; Arnaud da Cruz Paula; Caterina Marchio; Rita A Sakr; Raymond Lim; Lester D R Thompson; Simion I Chiosea; Raja R Seethala; Alena Skalova; Edward B Stelow; Isabel Fonseca; Adel Assaad; Christine How; Jianxin Wang; Richard de Borja; Michelle Chan-Seng-Yue; Christopher J Howlett; Anthony C Nichols; Y Hannah Wen; Nora Katabi; Nicholas Buchner; Laura Mullen; Thomas Kislinger; Bradly G Wouters; Fei-Fei Liu; Larry Norton; John D McPherson; Brian P Rubin; Blaise A Clarke; Britta Weigelt; Paul C Boutros; Jorge S Reis-Filho
Journal:  Nat Genet       Date:  2014-09-21       Impact factor: 38.330

8.  Mitochondrial diacylglycerol initiates protein-kinase D1-mediated ROS signaling.

Authors:  Catherine F Cowell; Heike Döppler; Irene K Yan; Angelika Hausser; Yoshio Umezawa; Peter Storz
Journal:  J Cell Sci       Date:  2009-03-03       Impact factor: 5.285

9.  Protein kinase d isoforms differentially modulate cofilin-driven directed cell migration.

Authors:  Heike Döppler; Ligia I Bastea; Sahra Borges; Samantha J Spratley; Sarah E Pearce; Peter Storz
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

10.  Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis.

Authors:  Sahra Borges; Heike Döppler; Edith A Perez; Cathy A Andorfer; Zhifu Sun; Panos Z Anastasiadis; E Thompson; Xochiquetzal J Geiger; Peter Storz
Journal:  Breast Cancer Res       Date:  2013-08-23       Impact factor: 6.466

View more
  24 in total

1.  The tumor suppressor protein DLC1 maintains protein kinase D activity and Golgi secretory function.

Authors:  Antje Jensch; Yannick Frey; Katharina Bitschar; Patrick Weber; Simone Schmid; Angelika Hausser; Monilola A Olayioye; Nicole E Radde
Journal:  J Biol Chem       Date:  2018-07-25       Impact factor: 5.157

2.  Cellular Protein Kinase D Modulators Play a Role during Multiple Steps of Herpes Simplex Virus 1 Egress.

Authors:  Élisabeth Roussel; Roger Lippé
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

Review 3.  Decoding the Cardiac Actions of Protein Kinase D Isoforms.

Authors:  Susan F Steinberg
Journal:  Mol Pharmacol       Date:  2021-09-16       Impact factor: 4.436

4.  Protein Kinase D: A Potential Therapeutic Target in Prostate Cancer.

Authors:  Adhiraj Roy; Q Jane Wang
Journal:  Mol Cell Pharmacol       Date:  2017

5.  Mutual inhibition between Prkd2 and Bcl6 controls T follicular helper cell differentiation.

Authors:  Takuma Misawa; Jeffrey A SoRelle; Jin Huk Choi; Tao Yue; Kuan-Wen Wang; William McAlpine; Jianhui Wang; Aijie Liu; Koichi Tabeta; Emre E Turer; Bret Evers; Evan Nair-Gill; Subhajit Poddar; Lijing Su; Feiya Ou; Liyang Yu; Jamie Russell; Sara Ludwig; Xiaoming Zhan; Sara Hildebrand; Xiaohong Li; Miao Tang; Anne R Murray; Eva Marie Y Moresco; Bruce Beutler
Journal:  Sci Immunol       Date:  2020-01-24

Review 6.  Endogenous and Exogenous Regulatory Signaling in the Secretory Pathway: Role of Golgi Signaling Molecules in Cancer.

Authors:  Simona Del Giudice; Valentina De Luca; Seyedehnegar Parizadeh; Domenico Russo; Alberto Luini; Rosaria Di Martino
Journal:  Front Cell Dev Biol       Date:  2022-03-23

7.  Development of an arteriolar niche and self-renewal of breast cancer stem cells by lysophosphatidic acid/protein kinase D signaling.

Authors:  Yinan Jiang; Yichen Guo; Jinjin Hao; Rachael Guenter; Justin Lathia; Adam W Beck; Reagan Hattaway; Douglas Hurst; Qiming Jane Wang; Yehe Liu; Qi Cao; Helen Krontiras; Herbert Chen; Roy Silverstein; Bin Ren
Journal:  Commun Biol       Date:  2021-06-24

Review 8.  Diverse roles of phosphatidate phosphatases in insect development and metabolism.

Authors:  Michael Lehmann
Journal:  Insect Biochem Mol Biol       Date:  2020-09-12       Impact factor: 4.421

9.  Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome.

Authors:  Lorenzo Bascetta; Marco Fantuz; Valeria Capaci; Galina V Beznoussenko; Roberta Sommaggio; Valeria Cancila; Andrea Bisso; Elena Campaner; Alexander A Mironov; Jacek R Wiśniewski; Luisa Ulloa Severino; Denis Scaini; Fleur Bossi; Jodi Lees; Noa Alon; Ledia Brunga; David Malkin; Silvano Piazza; Licio Collavin; Antonio Rosato; Silvio Bicciato; Claudio Tripodo; Fiamma Mantovani; Giannino Del Sal
Journal:  Nat Commun       Date:  2020-08-07       Impact factor: 14.919

10.  Protein Kinase D 1 Predicts Poor Treatment Response and Unfavorable Survival of Bortezomib-Based Treatment, and Its Knockdown Enhances Drug Sensitivity to Bortezomib in Multiple Myeloma.

Authors:  Xuesong Li; Ying Yang; Xue Yi
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.